Srinagarind Hospital
Khon Kaen, Changwat Khon Kaen, 40002, Thailand
NCT Number: NCT00120432
The purpose of this study is to compare the efficacy on pupillary dilation between the single dose versus the three doses of 1% tropicamide with 10% phenylephrine for complete ocular examination.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Interventional
Phase 3
Khon Kaen, Changwat Khon Kaen, 40002, Thailand
To the best of the authors' knowledge, there have been no clinical trials using an appropriate regimen for pupillary dilation up until now. Therefore, the authors were interested to find out the most appropriate regimen for complete ocular examination, based on the finding that a pupil diameter of 6 mm or greater is adequate for indirect ophthalmoscopy. The authors hypothesize that a single dose of 1% tropicamide and 10% phenylephrine is adequate to complete the job and are conducting this prospective randomized clinical controlled trial to prove the hypothesis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
single dose vs three doses of 1%tropicamide and 10%phenylephrine
Time frame: 30 min
Time frame: 30 min
Time frame: 30 min
Time frame: 30 min
Time frame: 30 min
Khon Kaen University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06455826
Eye Diseases, Eye Diseases, Hereditary
Jacksonville, Florida, United States
View Trial DetailsNCT02710916
Eye Diseases, Glaucoma
Bordeaux, Aquitaine, France
View Trial DetailsNCT05656027
Eye Diseases, Myopia
Chandler, Arizona, United States
View Trial DetailsNCT05753189
Eye Diseases, Myopia
Dothan, Alabama, United States
View Trial Details